Dose equivalency and efficacy of biosimilar erythropoietin stimulating agents: Data from real clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose equivalency and efficacy of biosimilar erythropoietin stimulating agents: Data from real clinical practice

Published:2020-06 Issue:3 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Gaipov Abduzhappar¹,Issanov Alpamys¹,Mursalova Zhanar²,Tulegenova Nazia²,Kakim Zoya³,Baizakov Mukhit⁴,Tuganbekova Saltanat⁵,Aljofan Mohamad⁶^ORCID

Affiliation:

1. Department of Clinical Sciences Nazarbayev University School of Medicine Nur‐Sultan Kazakhstan

2. Department of Dialysis Diaverum Kazakhstan Almaty Kazakhstan

3. Department of Dialysis Diaverum Kazakhstan Temirtau Kazakhstan

4. Department of Dialysis Hemodialysis Center Daru Aktobe Kazakhstan

5. Department of Internal Medicine National Scientific Medical Center Nur‐Sultan Kazakhstan

6. Department of Biomedical Sciences Nazarbayev University School of Medicine Nur‐Sultan Kazakhstan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.594

Reference15 articles.

1. Anemia of chronic kidney disease (vol 83, pg 613, 2016);Nakhoul G;Clev Clin J Med,2016

2. Colchicine Toxicity in End-Stage Renal Disease Patients

3. The Evolution of Biosimilars in Oncology, with a Focus on Trastuzumab

4. A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon ?;British Journal of Haematology;2021-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3